基于德尔菲法构建急性冠脉综合征患者PCI术后药物治疗管理模式

Medication Therapy Management Model for Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention Based on Delphi Method

目的:探讨急性冠脉综合征患者经皮冠状动脉介入治疗(PCI)术后药物治疗管理模式。方法:选择25名专家为函询对象,应用德尔菲法进行两轮函询征求专家对急性冠脉综合征患者PCI术后药物治疗管理模式的意见。结果:两轮咨询专家积极系数均为100%,专家权威系数为0.86和0.85,两轮专家函询的肯德尔协调系数(Kendall’s W)为0.301~0.343,差异有统计学意义。最终确定了急性冠脉综合征患者PCI术后药物治疗管理模式的3个维度和21个条目。结论:德尔菲法构建急性冠脉综合征患者PCI术后药物治疗管理模式具有较高的科学性和临床实用性。

Objective:To explore a model of medication therapy management(MTM)for acute coronary syndrome(ACS)patients after percutaneous coronary intervention(PCI).Methods:25 experts were chosen as the letter consultation objects.Delphi method was used twice to investigate the model of MTM for ACS patients after PCI.Results:The positive coefficients of two rounds of consultation experts were both 100%,and the expert authority coefficients were 0.86 and 0.85,respectively.The importance of the two rounds of expert correspondence and the feasibility of Kendall’s W were 0.301-0.343,and the difference was statistically significant.Finally,three dimensions and 21 items of MTM for ACS patients after PCI were determined.Conclusion:The MTM model for ACS patients after PCI by Delphi method has high scientific and clinical applicability.